Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used
| Image |  |
|---|---|
| Description | article |
| Author/s |
author: Carl Figdor Willem J Lesterhuis Jolanda de Vries Ruurd Torensma Gerty Schreibelt |
| Publication date | November 11, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |